Study conducted by the Cardiff University shows that one anti-inflammatory drug helps in reducing some types of cancer
The research team from Cardiff University discovered direct proof that those who used the anti-inflammatory treatment survived from cancer for a longer period of time than those who did not take the drug.
They also identified the essential processes that could explain the impact, including a reduction in cancer-related inflammation and irregular coagulation.
According to the findings of a few of the included research, taking aspirin may increase the likelihood of surviving cancer by approximately 20 percent.
Having said that, the experts also emphasized that additional data is still required because the findings of the studies varied substantially from one another.